Brief Reports Open Access
Copyright ©2005 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. May 21, 2005; 11(19): 2984-2989
Published online May 21, 2005. doi: 10.3748/wjg.v11.i19.2984
Protective effect of fufanghuangqiduogan against acute liver injury in mice
Shuang-Ying Gui, Wei Wei, Hua Wang, Li Wu, Wu-Yi Sun Cheng-Yi Wu, Institute of Clinical Pharmacology, Anhui Medical University, Hefei 230032, Anhui Province, China
Shuang-Ying Gui, Department of Pharmacy, Anhui College of TCM, Hefei 230031, Anhui Province, China
Author contributions: All authors contributed equally to the work.
Supported by the State High Technology Research and Development Program of China (863 Program), No. 2002AA2Z3235
Correspondence to: Professor Wei Wei, Institute of Clinical Pharmacology, Anhui Medical University, Hefei 230032, Anhui Province, China. wwei@ahmu.edu.cn
Telephone: +86-551-5161208 Fax: +86-551-5161208
Received: July 19, 2004
Revised: July 20, 2004
Accepted: September 4, 2004
Published online: May 21, 2005

Abstract

AIM: To study the effects and possible mechanisms of fufanghuangqiduogan (FFHQ) in mice with acute liver injury (ALI).

METHODS: ALI was successfully induced by injecting carbon tetrachloride (CCl4) intraperitoneally and by tail vein injection of Bacillus Calmette Guerin (BCG) and lipopolysaccharide (LPS) in mice, respectively. Each of the two model groups was divided into normal group, model group, FFHQ (60, 120 and 240 mg/kg) treatment groups, and bifendate treatment group. At the end of the experiment, levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST), content of malondialdehyde (MDA), activities of superoxide dismutase (SOD) and glutathione peroxidase (GSH-px) in liver homogenate were measured by biochemical methods. The activities of tumor necrosis factor-α (TNF-α) and interleukin-1 (IL-1) were determined by radio-immunoassay. Hepatic tissue sections were stained with hematoxylin and eosin and examined under a light microscope.

RESULTS: In the two models of ALI, FFHQ (60, 120, 240 mg/kg) was found to significantly decrease the serum transaminase (ALT, AST) activities. Meanwhile, FFHQ decreased MDA contents and upregulated the lower SOD and GSH-px levels in liver homogenate. Furthermore, in immunologic liver injury model, FFHQ decreased levels of TNF-α and IL-1 in serum. Histologic examination showed that FFHQ could attenuate the area and extent of necrosis, reduce the immigration of inflammatory cells.

CONCLUSION: FFHQ had protective effect on liver injury induced by either CCl4 or BCG+LPS in mice, and its mecha-nisms were related to free radical scavenging, increasing SOD and GSH-px activities and inhibiting the production of proinflammatory mediators.

Key Words: Fufanghuangqiduogan; Radix Paeonia Pall; Radix Astragali; Acute liver injury



INTRODUCTION

Acute liver injury (ALI) is a co-operative consequence of endotoxemia, microcirculation dysfunction as well as inflammatory cells (such as macrophage, lymphocyte) that release inflammatory mediators and cytokines (such as tumor necrosis factor-α (TNF-α), interleukin-1 (IL-1)) when stimulated. ALI is mostly induced by viral hepatitis, alcoholism, iron overload, or drug toxicity. It has a very high morbidity and mortality. The treatment might be anti-inflammatory or antioxidant action. Many modern Western medicines have been used to remedy ALI, but strategies are difficult to achieve satisfied outcomes due to their side effects. However, some traditional Chinese herbs (such as Radix Paeonia Pall, Radix Astragali, Radix Salviae Miltiorrhizae, Cordycep sinensis, Ginkgo biloba, Picrorhiza scrophulariflora) have been found to have particular advantages in therapeutic research of ALI and other liver disease for their definite effectiveness, cheap prices and negligible side effects[1-6]. Traditional Chinese medicine (TCM) treatment is based on overall analysis of symptoms and signs, and the physical condition of the patient[7]. Fufanghuangqiduogan (FFHQ) is an extract of prescription TCM consisting of Radix Astragali, Radix Paeonia lactiflora, etc. The present study aims at exploring the effects of FFHQ on the prevention of immunologic ALI induced by Bacillus Calmette Guerin (BCG)+ lipopolysaccharide (LPS) in mice and chemical ALI induced by CCl4 in mice, and the content of malondialdehyde (MDA) and the activities of superoxide dismutase (SOD) and glutathione peroxidase (GSH-px) in mice liver homogenate were determined in order to investigate its possible mechanisms.

MATERIALS AND METHODS
Drugs and materials

CCl4, purchased from Beijing Chemical Factory, was diluted to 0.1% in vegetable oil. LPS from Escherichia coli was obtained from Sigma Chemical Co. (St. Louis, MO, USA). BCG was purchased from Institute of Shanghai Biological Products. FFHQ is an extract of traditional Chinese herbs consisting of Radix Astragali, Radix Paeonia lactiflora and Radix Glycyrrhizae purchased from Anhui Heyitang Pharmacy, China. These herbs mixed up in specified ratio (1:4:0.8) were boiled with water and extracted by alcohol: 95% alcohol in liquid of these herbs by the volume proportion of 2:1 was mixed and stored at 0-4 °C for 24 h, then the sediments were filtered and the suspension including the protein and amylum was finally heated at 90-95 °C to evaporate the remaining alcohol and to obtain yellow brown powders. FFHQ was mainly composed of the total glucosides of Paeony (TGP), the total astragalosides (TAS), the total flavonoids of astragalus (TFA), astragalus polysaccharides and so on. TGP and TAS, accounting for 59.3%, were main effective components of FFHQ. FFHQ was dissolved into 0.5% sodium carboxymethylcellulose (CMC-Na) solutions before use. Commercial kits used for determining lipid peroxidation and SOD activity were obtained from the Jiancheng Institute of Biotechnology (Nanjing, China). Other chemicals used in these experiments were of analytical grade from comm-ercial sources.

Animals

Male Kunming mice (20±2 g) were obtained from the Animal Department of Anhui Medical University. Mice were maint-ained on 12-h light/dark cycles. Animals were allowed free access to food and water. All mice were fasted for 16 h prior to blood/tissue sampling. All experiments were performed in accordance with the institutional ethical guideline.

Establishment of chemical liver injury model[8-10]

A CCl4 0.1% vegetable oil solution was injected intraperitoneally into each animal in a dose of 10 mL/kg body weight. All the mice were anesthetized with ether, then killed by cervical dislocation 16 h after CCl4 injection and trunk blood was collected into heparinized tubes (50 U/mL) and centrifuged (1500 r/min, 10 min, 4 °C). Serum was aspirated and stored at -70 °C until assayed as described below. The liver was also removed and stored at -70 °C until use.

Establishment of immunological liver injury model[11]

A 2.5 mg dose of BCG (viable bacilli) suspended in 0.2 mL saline was injected via the tail vein into each animal, and 10 d later, injected with 7.5 µg LPS dissolved in 0.2 mL saline. The mice were anesthetized with ether, and then killed by cervical dislocation 16 h after LPS injection. The other method adopted in the case of pretreatment studies was the same as in CCl4-induced liver injury mentioned above.

Drug treatment

In the two model experiments, the animals were equally divided into six groups randomly which included normal, model control, FFHQ groups (three different doses) and bifendate. The mice in FFHQ groups received daily doses of 60, 120 or 240 mg/kg b.w. of FFHQ using an 18-gauge stainless steel animal feeding needle for 10 d prior to LPS injection and for 7 d prior to CCl4 injection, respectively. Mice in normal and model control group in the two model experiments were fed only with the same volume of vehicle.

Measurement of serum ALT, AST, TNF-α and IL-1

Serum alanine aminotransferase (ALT) and aspartate aminot-ransferase (AST) were determined using commercial kits produced by Jiancheng Institute of Biotechnology (Nanjing, China). The activities of ALT and AST were expressed as an international unit (U/L). Serum TNF-α and IL-1 were measured using commercial kits produced by Beijing Biotechnology Co., Ltd, and their levels were expressed as nanogram per milliliter.

Measurement of MDA, SOD and GSH-px in liver homogenate

Liver was thawed, weighed and homogenized in Tris-HCl (5 mmol/L containing 2 mmol/L EDTA, pH 7.4). Homog-enates were centrifuged (1000 r/min, 10 min, 4 °C) and the supernatant was used immediately for the assays of MDA and SOD. MDA, SOD and GSH-px were determined following the instructions on the kit. In brief, MDA in liver tissue was determined by the thiobarbituric acid method. All samples were assayed in triplicates. The content of MDA was expressed as nanomole per gram liver tissue. The assay for total SOD was based on its ability to inhibit the oxidation of oxyamine by the xanthine-xanthine oxidase system. The red product (nitrite) produced by the oxidation of oxyamine had an absorbance at 550 nm. One unit (U) of SOD activity was defined as the amount that reduced the absorbance at 550 nm by 50%. All samples were assayed in triplicates. Results were expressed as unit per gram liver tissue. GSH-px was measured by the DTNB method, and its content was expressed as unit per milligram protein.

Histologic analysis

Formalin-fixed specimens were embedded in paraffin and stained with hematoxylin and eosin for conventional morphologic evaluation. After decapitation of rats, small liver specimens were placed in 100 mL/L formalin solution and processed routinely by embedding in paraffin. Tissue sections (4-5 µm) were stained with hematoxylin and eosin and examined under light microscope (Olympus, Japan). An experienced histologist who was unaware of the treatment conditions made histologic assessments.

Statistical analysis

All values were presented as mean±SD. Statistical analysis of the data for multiple comparisons was performed by one-way analysis of variance followed by Duncan’s test. For a single comparison, the significance of differences between means was determined by Student’s t-test. A level of P<0.05 was taken as statistically significant.

RESULTS
Effect of FFHQ on serum ALT, AST, TNF-α and IL-1

Activities of both serum AST and ALT, indices of hepatic cell damage, were significantly higher in BCG+LPS-induced group and CCl4 group than in the control group in the two models. FFHQ (60, 120, 240 mg/kg b.w.) significantly reduced the activities of serum AST and ALT. Levels of TNF-α and IL-1 in serum were significantly higher in BCG+LPS-induced group than in the control group in the immunologic mice model. FFHQ (60, 120, 240 mg/kg b.w.) significantly reduced the levels of serum TNF-α and IL-1 in the immunologic mice model (Tables 1 and 2).

Table 1 Effects of FFHQ on serum ALT, AST, TNF-α and IL-1 in immunologic liver injury in mice (n = 10, mean±SD).
GroupDose (mg/kg b.w.)ALT (U/L)AST (U/L)TNF-α (ng/mL)IL-1 ng/mL
Normal---22.3±6.131.5±8.51.29±0.410.157±0.054
Model---204.3±49.6d197.6±42.3d3.95±1.24d0.341±0.101d
FFHQ60171.6±33.7a172.0±35.8a3.00±0.98a0.289±0.068a
120131.1±24.8b151.2±39.8b2.76±0.63b0.244±0.049b
240129.7±26.5b143.5±30.9b2.61±0.55b0.273±0.051b
Bifendate10089.6±21.3b95.4±28.3b2.89±0.92a0.279±0.046a
Table 2 Effects of FFHQ on serum ALT and AST in chemical ALI in mice (n = 10, mean±SD).
GroupDose (mg/kg b.w.)ALT (U/L)AST (U/L)
Normal---26.4±8.234.1±9.3
Model---222.4±35.9d231.8±40.0d
FFHQ60181.6±30.7a182.0±35.8a
120153.1±34.8b161.2±39.8b
240144.7±46.5b153.5±30.9b
Bifendate100103.5±29.8b139.3±31.6b
Effect of FFHQ on liver homogenate MDA, total SOD and GSH-px

Liver homogenate MDA content in BCG+LPS-induced group and CCl4 group was significantly higher than that in the control group in the two models, while liver homogenate total SOD activity and the GSH-px level were sharply decreased. FFHQ (60, 120, 240 mg/kg b.w.) could not only significantly attenuate MDA generation, but evidently increased the liver total SOD activity and the GSH-px level in the two mice models (Tables 3 and 4).

Table 3 Effects of FFHQ on MDA, SOD and GSH-px of immunological ALI mice’s liver homogenate (n = 10, mean±SD).
GroupDose (mg/kg b.w.)MDA (nmol/g tissue)SOD (U/g tissue)GSH-px (U/mg protein)
Normal---6.541.82396.660.6141.427.5
Model---15.183.57d181.340.7 d97.924.7d
FFHQ6012.573.15a212.339.8a116.529.1a
12010.742.34b252.142.0b129.530.5b
24010.082.28b269.052.7b133.134.1b
Bifendate10012.033.21a193.840.5107.630.5
Table 4 Effects of FFHQ on MDA, SOD and GSH-px of chemical ALI mice’s liver homogenate (n = 10, mean±SD).
GroupDose (mg/kg b.w.)MDA (nmol/g tissue)SOD (U/g tissue)GSH-px (U/mg protein)
Normal---6.762.3440.551.8136.424.5
Model---18.684.72d204.334.1d91.921.2d
FFHQ6013.212.88b310.135.5 b105.523.6a
12012.363.19b321.339.2b121.124.6b
24012.083.28b337.035.1b124.327.9b
Bifendate10012.292.67b221.638.598.322.5
Histologic results

In the two models, normal mice had no pathologic abnormality. Liver parenchyma was in good morphology and hepatocytes were arranged around the central vein. No congestion and inflammation were noticed in the sinusoids (Figures 1A and 2A). In the two models, model group mice had severe pathologic abnormality. Hepatocytes were prominent with marked vacuolization; moreover, hepatocytes necrosis, striped necrosis, bridging necrosis appeared and inflammatory cells were arranged around the necrotic tissue. Congestions in liver sinusoids were significant with scattering immersion of inflammatory cells (Figures 1B and 2B). In the two models, the area and extent of necrosis in FFHQ-treated groups attenuated and the immigration of inflammatory cells reduced. Liver parenchyma was well preserved with radially arranged hepatocytes around the central vein. Regular sinusoidal structures were noticed without congestion (Figures 1C and 2C).

Figure 1
Figure 1 Histologic results of tissues stained with hematoxylin and eosin under light microscope in immunologic ALI mice. A: Normal control group; B: model group; C: FFHQ-treated group.
Figure 2
Figure 2 Histologic results of tissues stained with hematoxylin and eosin under light microscope in chemical ALI in mice. A: Normal control group; B: model group; C: FFHQ-treated group.
DISCUSSION

FFHQ was an extract of Chinese herbs prescription that has various kinds of pharmacologic actions. In the prescription, the main Chinese herbs such as Radix Astragali and Radix Paeonia lactiflora have been used to relieve the pain and be an effective prescription for treatment of liver disease and other diseases[1,2,7,12,13]. FFHQ has some active compounds, such as TGP (consist of paeoniflorin, albiflorin, benzoylpaeoniflorin, oxypaeoniflorin, paeonin, etc.), TAS (consist of astragaloside I-VI, soyasaponin, etc.), TFA, astragalus polysaccharides and so on. The previous results from our laboratory showed that TGP was effective against ALI induced by CCl4, D-galactosamine (D-GalN) and BCG+LPS in mice and chronic liver[1]. In vivo and in vitro, TGP showed obvious anti-inflammatory and antioxidative activities in other diseases besides in liver disease. For example, it was found that treatment of AA rats with TGP (50 mg/kg, ig (14-28 d)) could inhibit the elevated level of MDA and NO, and upregulated the lowered activities of SOD and GSH-px[14,15]. In vitro, TGP could scavenge OH· and O2[16,17]. It was reported[13] that TAS could protect liver from chemical injury induced by CCl4, D-GalN and acetaminophen in mice. TAS could impede the elevation of ALT level, decrease the MDA content and increase the GSH concentration in mice liver homogenate. Obvious improvements of histologic changes were also observed. In vitro, TAS (0.75 μmol/L-0.18 mmol/L) could decrease elevated ALT level in hepatocytes separated from rats. Previous studies of our institute showed that TAS had an antinociceptive effect on formalin test in mice that related to its inhibitory effect on the production of NO. Besides, astragalus polysaccharide was found to have immunoregulatory activity and was used in various kinds of immunologic diseases[17]. In our previous study, the optimum proportion of herbs in FFHQ prescription was obtained by uniform design in ALI mice. On the basis of the optimum proportion, FFHQ extracts were produced with the method stated in the part of “Drugs and materials”. In the present study, the two kinds of ALI models in mice were successfully established, namely immunologic ALI model induced by BCG+LPS and chemical ALI model induced by CCl4 to observe the protective effects and its probable mechanisms of FFHQ.

CCl4 is a well-known hepatotoxic chemical[8,10,18,19]. The main cause of ALI by CCl4 is free radicals of its metabolites. By the activation of liver cytochrome P-450, CCl4 generates methyltrichloride radicals (CCl3), which are highly unstable and immediately react with membrane components. They form covalent bonds with unsaturated fatty acids, or take a hydrogen atom from the unsaturated fatty acids of membrane lipids, resulting in the production of chloroform and lipid radicals. The lipid radicals react with molecular oxygen, which initiates peroxidative decomposition of phospholipids in the endoplasmic reticulum. The peroxidation process results in the release of soluble products that may affect cell membrane. Cell membrane integrity is broken and the enzymes (such as ALT, AST, etc.) in cell plasma leak out. The free radicals and its triggered lipid peroxidation were involved in the main mechanisms by which CCl4 induced ALI[20-25]. MDA was one of the main lipid peroxidation products, its elevated levels could reflect the degrees of lipid peroxidation injury in hepatocytes. However, SOD is a scavenger of peroxide anion radicals[26], which could inhibit the initiation of lipid peroxidation by free radicals; GHS-px could particularly catalyze the reductive action of GSH to H2O2 to protect the integrity of plasma membrane and functions. The present study showed that level of serum ALT, AST and the content of MDA in liver homogenate increased in the model group mice and the activities of SOD and GSH-px decreased correspondingly. FFHQ decreased the elevated level of ALT and AST, markedly inhibited the increase of MDA level and upregulated lower level of the activities of SOD and GSH-px in different extents, in a dose-dependent manner. These results indicated that median and high doses of FFHQ had potential action against lipid peroxidation, and this effect perhaps is the main mechanism of protection on ALI. The results were consistent with that TGP and TAS showed anti-inflammatory and antioxidate activities in our previous and in the studies of others.

Injection of BCG followed by LPS is useful for the creation of experimental models of immunologic ALI[11,27,28]. In the present study, immunologic ALI in mice was successfully induced by BCG+LPS. On this basis, administration of FFHQ in vivo resulted in marked reduction of liver injury, as demonstrated by significant reduction of the serum transaminase concentration and amelioration of the severe hepatic pathologic abnormalities. Meanwhile, FFHQ decreased MDA content and increased GSH-px and total SOD activities in liver homogenate, in a dose-dependent manner. Furthermore, FFHQ significantly reduced TNF-α and IL-1 production in serum, in a dose-dependent manner. In the present study, the effects of FFHQ on two models in mice were investigated first. The results showed that FFHQ deceased MDA content in liver homogenate, meanwhile, SOD and GSH-px activities rose significantly. Those results are in accordance with the findings of FFHQ’s antioxidant properties.

TNF-α is a multifunctional cytokine mostly secreted by inflammatory cells and has been implicated in a number of liver diseases. TNF-α has been proven to be the key mediator and cytokine in the destruction of hepatocyte in human liver diseases[29,30]. Many previous studies have showed that TNF-α could mediate cell injuries in liver caused by alcoholism, endotoxin, reperfusion, primary graft nonfunctional and graft rejection and so on, and the activity of TNF-α was positively related with the extent of liver necrosis[28-31]. At the same time, TNF-α can activate nuclear transcription factor-kappa B of hepatocytes, Kupffer cells and endotheliocyte, which increases expression of intercellular adhesion molecule-1, vascular-cell adhesion molecule-1 and selection, these inflammatory factors further impel the inflammatory injury of hepatocytes[32,33]. The present study is in accordance with the reported results. In the two ALI models in mice, serum TNF-α level in model groups was significantly higher than that in control groups. IL-1 is another critical inflammatory mediator and cytokine in ALI. Although IL-1 itself has no damage on liver, its elevation could stimulate inflammatory cells to excrete many other cytokines including TNF-α, IL-6 and IL-8, which contribute to ALI[34]. Our data provided further evidence for the role of cytokines including TNF-α and IL-1 during ALI. Serum level of TNF-α and IL-1 elevated significantly in model group in immunologic ALI mice model. Median and high doses of FFHQ significantly reduced the elevated level of TNF-α and IL-1 in mice serum. Therefore, inhibition of pro-inflammatory mediator and cytokines is partly the mechanisms of FFHQ protective effect on ALI.

In the two model experiments, histologic changes, such as hemorrhage and necrosis in hepatic lobules, inflammatory infiltration of lymphocytes and Kupffer cells around the central vein, were simultaneously improved in FFHQ treatment groups. All results mentioned above suggested that FFHQ may not only be an anti-inflammatory agent, but also be used as an antioxidative therapy for ALI in mice.

In summary, the present study further demonstrated that inflammatory reaction, free radicals and its triggered lipid peroxidation are main pathologic characteristics of ALI. FFHQ has protective effect either on chemical ALI in mice or on immunologic ALI in mice. The mechanisms of FFHQ on ALI may be related to its immunoregulatory properties and antioxidant, such as free radical scavenging, increased SOD, GSH-px activities and proinflammatory mediators. To conform to the modernization of TCM, the study on active components about the prescription of FFHQ needs to be developed further. Both experiments to extract, isolate and identify the active components about the prescription of FFHQ and studies on the mechanisms involved are now in progress.

Footnotes

Science Editor Guo SY Language Editor Elsevier HK

References
1.  Dai LM, Chen XG, Xu SY. Protective effects of total glucosides of paeoney on experimental hepatitis. Zhongguo Yaolixue Tongbao. 1993;9:449-453.  [PubMed]  [DOI]  [Cited in This Article: ]
2.  Shen WM, Wang CB, Wang DQ, Tian YP, Yan GT, Hao XH. The protective effects of TFA on reperfusion induced hepatic injury in hemorrhagic shock. Zhongguo Yaolixue Tongbao. 1997;13:532-534.  [PubMed]  [DOI]  [Cited in This Article: ]
3.  Singh AK, Mani H, Seth P, Gaddipati JP, Kumari R, Banuadha KK, Sharma SC, Kulshreshtha DK, Maheshwari RK. Picroliv preconditioning protects the rat liver against ischemia-reperfusion injury. Eur J Pharmacol. 2000;395:229-239.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 27]  [Cited by in F6Publishing: 31]  [Article Influence: 1.3]  [Reference Citation Analysis (0)]
4.  McKenna DJ, Jones K, Hughes K. Efficacy, safety, and use of ginkgo biloba in clinical and preclinical applications. Altern Ther Health Med. 2001;7:70-86, 88-90.  [PubMed]  [DOI]  [Cited in This Article: ]
5.  Diamond BJ, Shiflett SC, Feiwel N, Matheis RJ, Noskin O, Richards JA, Schoenberger NE. Ginkgo biloba extract: mechanisms and clinical indications. Arch Phys Med Rehabil. 2000;81:668-678.  [PubMed]  [DOI]  [Cited in This Article: ]
6.  Hase K, Kasimu R, Basnet P, Kadota S, Namba T. Preventive effect of lithospermate B from Salvia miltiorhiza on experimental hepatitis induced by carbon tetrachloride or D-galactosamine/lipopolysaccharide. Planta Med. 1997;63:22-26.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 61]  [Cited by in F6Publishing: 48]  [Article Influence: 1.8]  [Reference Citation Analysis (0)]
7.  Lin KJ, Chen JC, Tsauer W, Lin CC, Lin JG, Tsai CC. Prophylactic effect of four prescriptions of traditional Chinese medicine on alpha-naphthylisothiocyanate and carbon tetrachloride induced toxicity in rats. Acta Pharmacol Sin. 2001;22:1159-1167.  [PubMed]  [DOI]  [Cited in This Article: ]
8.  Mansour MA, Ginawi OT, El-Hadiyah T, El-Khatib AS, Al-Shabanah OA, Al-Sawaf HA. Effects of volatile oil constituents of Nigella sativa on carbon tetrachloride-induced hepatotoxicity in mice: evidence for antioxidant effects of thymoquinone. Res Commun Mol Pathol Pharmacol. 2001;110:239-251.  [PubMed]  [DOI]  [Cited in This Article: ]
9.  Santra A, Das S, Maity A, Rao SB, Mazumder DN. Prevention of carbon tetrachloride-induced hepatic injury in mice by Picrorhiza kurrooa. Indian J Gastroenterol. 1998;17:6-9.  [PubMed]  [DOI]  [Cited in This Article: ]
10.  Murakami T, Nagamura Y, Hirano K. The recovering effect of betaine on carbon tetrachloride-induced liver injury. J Nutr Sci Vitaminol (Tokyo). 1998;44:249-255.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 19]  [Cited by in F6Publishing: 18]  [Article Influence: 0.7]  [Reference Citation Analysis (0)]
11.  Ferluga J. Tuberculin hypersensitivity hepatitis in mice infected with Mycobacterium bovis (BCG). Am J Pathol. 1981;105:82-90.  [PubMed]  [DOI]  [Cited in This Article: ]
12.  Yang Q, Lu JT, Zhou AW, Wang B, He GW, Chen MZ. Antinociceptive effect of astragalosides and its mechanism of action. Acta Pharmacol Sin. 2001;22:809-812.  [PubMed]  [DOI]  [Cited in This Article: ]
13.  Zhang YD, Shen JP, Zhu SH, Huang DK, Ding Y, Zhang XL. Effects of astragalus (ASI, SK) on experimental liver injury. YaoXue XueBao. 1992;27:401-406.  [PubMed]  [DOI]  [Cited in This Article: ]
14.  Li J, Tang XL, Chen MZ, Xu SY. Immunoregulatory mechanisms of total glucosides of paeoney in adjuvant arthritic rats. Zhongguo Yaolixue Tongbao. 1995;11:475-478.  [PubMed]  [DOI]  [Cited in This Article: ]
15.  Ge ZD, Wei W, Shen YX, Wang B, Ding CH, Zhou AW, Zhang AP, Xu SY. Effects of paeoniflorin, total glucosides of paeony removed paeoniflorin on interleukin 2 production by splenic lymphocytes form adjuvant arthritic rats. Anhui Yike Daxue Xuebao. 1996;31:4-6.  [PubMed]  [DOI]  [Cited in This Article: ]
16.  Gao BB, Dai LM, Xu SY. The scavenging activities of TGM and TGP on free radicals. Wuifang Yixueyuan Xuebao. 1996;18:43-46.  [PubMed]  [DOI]  [Cited in This Article: ]
17.  Xu DJ, Chen MZ. Effect of astragalus polysaccharide on immunologic function in mice. Anhui Yiyao. 2003;7:418-419.  [PubMed]  [DOI]  [Cited in This Article: ]
18.  Yu C, Wang F, Jin C, Wu X, Chan WK, McKeehan WL. Increased carbon tetrachloride-induced liver injury and fibrosis in FGFR4-deficient mice. Am J Pathol. 2002;161:2003-2010.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 94]  [Cited by in F6Publishing: 95]  [Article Influence: 4.3]  [Reference Citation Analysis (0)]
19.  Marucci L, Alpini G, Glaser SS, Alvaro D, Benedetti A, Francis H, Phinizy JL, Marzioni M, Mauldin J, Venter J. Taurocholate feeding prevents CCl4-induced damage of large cholangiocytes through PI3-kinase-dependent mechanism. Am J Physiol Gastrointest Liver Physiol. 2003;284:G290-G301.  [PubMed]  [DOI]  [Cited in This Article: ]
20.  Marathe GK, Harrison KA, Roberts LJ, Morrow JD, Murphy RC, Tjoelker LW, Prescott SM, Zimmerman GA, McIntyre TM. Identification of platelet-activating factor as the inflammatory lipid mediator in CCl4-metabolizing rat liver. J Lipid Res. 2001;42:587-596.  [PubMed]  [DOI]  [Cited in This Article: ]
21.  Terao J, Asano I, Matsushita S. High-performance liquid chromatographic determination of phospholipid peroxidation products of rat liver after carbon tetrachloride administration. Arch Biochem Biophys. 1984;235:326-333.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 52]  [Cited by in F6Publishing: 53]  [Article Influence: 1.3]  [Reference Citation Analysis (0)]
22.  elSisi AE, Earnest DL, Sipes IG. Vitamin A potentiation of carbon tetrachloride hepatotoxicity: enhanced lipid peroxidation without enhanced biotransformation. Toxicol Appl Pharmacol. 1993;119:289-294.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 25]  [Cited by in F6Publishing: 24]  [Article Influence: 0.8]  [Reference Citation Analysis (0)]
23.  elSisi AE, Earnest DL, Sipes IG. Vitamin A potentiation of carbon tetrachloride hepatotoxicity: role of liver macrophages and active oxygen species. Toxicol Appl Pharmacol. 1993;119:295-301.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 71]  [Cited by in F6Publishing: 72]  [Article Influence: 2.3]  [Reference Citation Analysis (0)]
24.  Bruckner JV, Ramanathan R, Lee KM, Muralidhara S. Mechanisms of circadian rhythmicity of carbon tetrachloride hepatotoxicity. J Pharmacol Exp Ther. 2002;300:273-281.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 53]  [Cited by in F6Publishing: 57]  [Article Influence: 2.6]  [Reference Citation Analysis (0)]
25.  Badger DA, Sauer JM, Hoglen NC, Jolley CS, Sipes IG. The role of inflammatory cells and cytochrome P450 in the potentiation of CCl4-induced liver injury by a single dose of retinol. Toxicol Appl Pharmacol. 1996;141:507-519.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 60]  [Cited by in F6Publishing: 59]  [Article Influence: 2.1]  [Reference Citation Analysis (0)]
26.  Hsu CT. The role of the autonomic nervous system in chemically-induced liver damage and repair--using the essential hypertensive animal model (SHR). J Auton Nerv Syst. 1995;51:135-142.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 23]  [Cited by in F6Publishing: 22]  [Article Influence: 0.8]  [Reference Citation Analysis (0)]
27.  Shands JW, Senterfitt VC. Endotoxin-induced hepatic damage in BCG-infected mice. Am J Pathol. 1972;67:23-40.  [PubMed]  [DOI]  [Cited in This Article: ]
28.  Nagai H, Yakuo I, Yamada H, Shimazawa T, Koda A, Niu K, Asano K, Shimizu T, Kasahara M. Liver injury model in mice for immunopharmacological study. Jpn J Pharmacol. 1988;46:247-254.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 15]  [Cited by in F6Publishing: 16]  [Article Influence: 0.4]  [Reference Citation Analysis (0)]
29.  Streetz K, Leifeld L, Grundmann D, Ramakers J, Eckert K, Spengler U, Brenner D, Manns M, Trautwein C. Tumor necrosis factor alpha in the pathogenesis of human and murine fulminant hepatic failure. Gastroenterology. 2000;119:446-460.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 162]  [Cited by in F6Publishing: 170]  [Article Influence: 7.1]  [Reference Citation Analysis (0)]
30.  Crespo J, Cayón A, Fernández-Gil P, Hernández-Guerra M, Mayorga M, Domínguez-Díez A, Fernández-Escalante JC, Pons-Romero F. Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients. Hepatology. 2001;34:1158-1163.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 485]  [Cited by in F6Publishing: 493]  [Article Influence: 21.4]  [Reference Citation Analysis (0)]
31.  Colletti LM, Cortis A, Lukacs N, Kunkel SL, Green M, Strieter RM. Tumor necrosis factor up-regulates intercellular adhesion molecule 1, which is important in the neutrophil-dependent lung and liver injury associated with hepatic ischemia and reperfusion in the rat. Shock. 1998;10:182-191.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 138]  [Cited by in F6Publishing: 144]  [Article Influence: 5.5]  [Reference Citation Analysis (0)]
32.  Issekutz TB. Effects of six different cytokines on lymphocyte adherence to microvascular endothelium and in vivo lymphocyte migration in the rat. J Immunol. 1990;144:2140-2146.  [PubMed]  [DOI]  [Cited in This Article: ]
33.  Essani NA, McGuire GM, Manning AM, Jaeschke H. Endotoxin-induced activation of the nuclear transcription factor kappa B and expression of E-selectin messenger RNA in hepatocytes, Kupffer cells, and endothelial cells in vivo. J Immunol. 1996;156:2956-2963.  [PubMed]  [DOI]  [Cited in This Article: ]
34.  Muto Y, Nouri-Aria KT, Meager A, Alexander GJ, Eddleston AL, Williams R. Enhanced tumour necrosis factor and interleukin-1 in fulminant hepatic failure. Lancet. 1988;2:72-74.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 206]  [Cited by in F6Publishing: 206]  [Article Influence: 5.7]  [Reference Citation Analysis (0)]